CogniCurrent

COGNICURRENT

Feb 4 • 10:02 UTC • 🇪🇸 Spain • El País

Novo Nordisk's shares plummet amid strong sales forecast drop for Ozempic and Wegovy this year

Novo Nordisk's stock fell by up to 20% following a forecast predicting a significant decline in sales for its weight loss drugs Ozempic and Wegovy, resulting in a 13% revenue cut for 2026.

#novo nordisk #ozempic #wegovy #stock market #health
Read Original Back to Feed

📡 Similar Coverage